Riskpilot← Back to searchSign inGet full accessXymbiotec System AB
ABActiveOrg 5565606828Västra Fageredsvägen 22Business and other management consultancy activities · NACE 7020Est. 19985-9 employees
Revenue 2024
SEK 3,7M
+15% vs 2023
EBITDA margin
8.3%
+21% vs 2023
Equity ratio
34.3%
Financial strength
Net profit 2024
SEK 309K
-9% vs 2023
| Revenue | SEK 3,7M | +15% |
| EBITDA | SEK 308K | +21% |
| Net profit | SEK 309K | -9% |
| Total assets | SEK 9,3M | +10% |
| Equity | SEK 3,2M | +11% |
| Employees | — | — |
Legal name
Xymbiotec System AB
Org number
5565606828
Legal form
Aktiebolag
NACE code
7020 · Business and other management consultancy activities
Founded
13 oktober 1998
Share capital
SEK 100 000
Employees
5-9
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall erbjuda sina kunder innovativa lösningar inom data och teknik samt idka därmed förenlig verksamhet. Bolaget skall också bygga, äga och förvalta fastigheter samt idka därmed förenlig verksamhet.
Address
Västra Fageredsvägen 22
Phone
+46707980740
Email
christian.petterson@xymbiotec.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 5 157 | 6 539 | 5 085 | 4 467 | 3 492 | 3 261 | 3 737 |
| Staff expenses | — | — | — | — | — | — | — | −2 057 | −2 523 | −2 686 |
| EBITDA | 512 | 475 | 305 | −1 070 | 36 | 24 | 416 | 321 | 254 | 308 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −112 | −112 | −112 | −112 | −112 |
| EBIT | 512 | 475 | 305 | −1 070 | 36 | −88 | 304 | 210 | 143 | 197 |
| Net financials | −4 | — | −7 | −5 | −6 | −4 | −1 | −5 | 1 | 1 |
| Profit before tax | 391 | 357 | 207 | 276 | 31 | 678 | 453 | 227 | 434 | 396 |
| Tax | −89 | −87 | −62 | −66 | −13 | −152 | −94 | −49 | −93 | −87 |
| Net profit | 302 | 270 | 145 | 210 | 18 | 526 | 359 | 179 | 341 | 309 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 3 112 | 5 011 | 6 486 | 7 685 | 8 337 | 9 098 | 8 450 | 7 642 | 8 450 | 9 267 |
| Equity | 825 | 1 095 | 1 239 | 1 449 | 1 467 | 1 993 | 2 351 | 2 530 | 2 871 | 3 180 |
| Long-term debt | 291 | 2 643 | 3 749 | 5 387 | 5 919 | 5 595 | 4 902 | 3 171 | 0 | — |
| Short-term debt | 1 756 | 915 | 1 047 | 749 | 852 | 1 182 | 718 | 1 383 | 4 912 | 5 419 |
| Total debt | 2 047 | 3 558 | 4 796 | 6 136 | 6 771 | 6 777 | 5 620 | 4 555 | 4 912 | 5 419 |
EBITDA margin
8.3%
This company
15.8%
Market median
-47% vs market
20152024
Equity ratio
34.3%
This company
38.2%
Market median
+10% vs market
20152024
Return on equity
9.7%
This company
18.4%
Market median
-47% vs market
20152024
Net profit margin
8.3%
This company
8.1%
Market median
+2% vs market
20152024
Asset turnover
0.40×
This company
1.12×
Market median
-64% vs market
20152024
Debt / equity
1.91×
This company
0.62×
Market median
-208% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
OI Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
CJ Chief Auditor | Chief Auditor | 2020 | — | — |
SM Chief Auditor | Chief Auditor | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2020 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Xymbiotec Aktiebolag | Company | 92.0% | 92.0% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Xymbiotec Aktiebolag
Xymbiotec System AB Board members of Xymbiotec System AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Olof Ivar Christian Petersson | Chief Executive Officer | 0 companies |
| Claes Jonas Töllbäck | Chief Auditor | 0 companies |
| Sara Maria Svensson Emanuelsson | Chief Auditor | 0 companies |
| Lisbet Mariann Dahlén | Deputy Board Member | 0 companies |